CAMP and psoriasis: For example, LL-37 levels were significantly elevated in serum specimens from multiply injured patients (0.02 ∼0.04 vs. 0.002 μM for controls) (Lippross et al., 2012), and LL-37 was highly expressed in the skin of psoriasis patients (Reinholz et al., 2012).